Literature DB >> 8761941

Conversion of dermal fibroblasts to a myogenic lineage is induced by a soluble factor derived from myoblasts.

C J Wise1, D J Watt, G E Jones.   

Abstract

The limb and axial skeletal muscles of mammals originate from somitic dermomyotome, which during early development separates to form two discrete structures, the dermatome and the myotome. The latter cell mass gives rise to the muscle-forming lineage while cells of the dermatome will form the skin dermal fibroblast population of the dorsal regions of the body. It has been generally accepted for some time that myotome-derived myoblasts were the sole source of muscle fibre nuclei, but evidence has recently been presented from several laboratories that fibroblasts can fuse with myoblasts to contribute active nuclei to the resulting myotubes. We report here an investigation into the myogenic capacity of fibroblasts. Confluent monocultures of mouse dermal fibroblasts, muscle fibroblasts, and C2C12 myoblasts each retain their individual phenotype when maintained for periods up to 7 days in culture. We also grew isolated colonies of fibroblasts and myoblasts in an arrangement which allowed free exchange of tissue culture medium between the 2 cell types. We found evidence of the conversion of dermal fibroblasts to a myogenic lineage as measured by the appearance of MyoD-positive cells expressing the muscle-specific intermediate filament desmin. In addition, dermal fibroblast cultures contained multinucleate syncytia positive for MyoD and containing sarcomeric myosin heavy chain. In contrast, muscle-derived fibroblasts showed no evidence of myogenic conversion when maintained in identical culture conditions. We prepared conditioned medium from confluent cultures of C2C12 myoblasts and added this material to confluent monocultures of either dermal or muscle fibroblasts. While muscle fibroblasts showed no phenotypic alterations, cultures of dermal fibroblasts responded to myoblast conditioned medium by converting to a myogenic lineage as judged by expression of MyoD and desmin. We conclude that a proportion of dermal fibroblasts retain a myogenic capacity into stages well beyond their early association with myoblasts in the dermomyotome.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8761941     DOI: 10.1002/(SICI)1097-4644(19960601)61:3%3C363::AID-JCB4%3E3.0.CO;2-R

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  5 in total

1.  Dermal fibroblasts participate in the formation of new muscle fibres when implanted into regenerating normal mouse muscle.

Authors:  D Pye; D J Watt
Journal:  J Anat       Date:  2001-02       Impact factor: 2.610

Review 2.  The involvement of galectin-1 in skeletal muscle determination, differentiation and regeneration.

Authors:  Diana J Watt; Gareth E Jones; Kirstin Goldring
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

3.  Harnessing the therapeutic potential of myogenic stem cells.

Authors:  Jason D White; Miranda D Grounds
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

4.  Cellular senescence induces replication stress with almost no affect on DNA replication timing.

Authors:  Juan Carlos Rivera-Mulia; Hélène Schwerer; Emilie Besnard; Romain Desprat; Claudia Trevilla-Garcia; Jiao Sima; Paul Bensadoun; Anissa Zouaoui; David M Gilbert; Jean-Marc Lemaitre
Journal:  Cell Cycle       Date:  2018-08-21       Impact factor: 4.534

Review 5.  Mesenchymal stem cells: emerging therapy for Duchenne muscular dystrophy.

Authors:  Chad D Markert; Anthony Atala; Jennifer K Cann; George Christ; Mark Furth; Fabrisia Ambrosio; Martin K Childers
Journal:  PM R       Date:  2009-06       Impact factor: 2.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.